# ALVIMOPAN
> **ANDA208295** · Abbreviated New Drug Application (Generic) · Sponsor: WATSON LABS TEVA · Approved 2019-12-19
## Drug
- **FDA Application Number:** ANDA208295
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** ALVIMOPAN
- **Generic name:** ALVIMOPAN
- **Active ingredients:** ALVIMOPAN
- **Dosage form:** CAPSULE
- **Route:** ORAL
- **Marketing status:** Prescription
- **Sponsor:** WATSON LABS TEVA
- **Manufacturer:** Actavis Pharma, Inc.
- **First approval:** 2019-12-19
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=208295)
---
*AI Analytics · CC0 1.0*